Detalhe da pesquisa
1.
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Int J Cancer
; 154(6): 1057-1072, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078628
2.
CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Small Methods
; 7(6): e2201605, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908010